Spanish Red Biotech Pipeline

MSD

Pembrolizumab

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: MSI-H or dMMR Stage IV Colorectal Carcinoma (after progression of First and second line Standard Therapy)
Phase: 2Phase II in Spain, 1Phase I